Pelthos Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $15,603 | $10,906 | $9,389 | $7,406 |
Gross Profit | 10,672 | 5,594 | 4,999 | 2,431 |
EBITDA | -15,934 | -6,385 | -26,055 | -14,678 |
EBIT | -17,323 | -7,885 | -27,272 | -15,357 |
Net Income | -23,417 | -10,238 | -21,664 | -16,238 |
Net Change In Cash | 15,603 | 10,906 | 9,389 | 7,406 |
Free Cash Flow | -7,666 | -13,320 | -6,351 | -15,258 |
Cash | 24,560 | 32,226 | 18,023 | 14,253 |
Basic Shares | 3,539 | 3,311 | 3,154 | 640 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $16,795 | $0 | $0 | $0 |
Gross Profit | 7,430 | 0 | ||
EBITDA | -45,409 | -7,168 | -6,862 | -2,318 |
EBIT | -47,694 | |||
Net Income | -43,319 | -7,955 | -7,380 | -2,458 |
Net Change In Cash | 16,795 | 0 | 0 | 0 |
Free Cash Flow | -22,689 | -5,792 | -981 | -1,567 |
Cash | 18,023 | 513 | 96 | 55 |
Basic Shares | 1,880 | 587 | 576 | 576 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$6.62 |
2026-03-31 | -$4.66 |
2025-12-31 | -$2.69 |
2025-09-30 | -$5.30 |